Sequana Medical

• NCT05965934

  Phase 1/2, Status unknown, 33 people, 28 Jul 2023

• The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology

  Grants or research support, 13 Aug 2025

• Risk for Heart Failure and Atrial Fibrillation Across the Lifespan for Carriers of the Amyloidogenic p.V142I TTR Variant

  Consulting or advice, 23 Jul 2025

Sources: pubmed.ncbi.nlm.nih.gov